AP Pharma Inc. (HRTX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
23-May-19 8:39 AM
View: 
Poyhonen John
Director
AP Pharma Inc. (HRTX) 22-May-19Market Purchase 3,000$17.55$52,650.0030%
10.0K to 13.0K
(< 1%)
16-May-19 8:44 AM
View: 
Christian Waage
Director
AP Pharma Inc. (HRTX) 15-May-19Market Purchase 1,400$18.04$25,261.70100%
0 to 1.4K
< 1%
02-May-19 8:40 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 01-May-19Market Sale (Planned) 1,109$18.86$20,918.10(100%)
1.11K to 0
02-May-19 8:40 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 30-Apr-19Acquisition (other) 1,109$18.43$20,436.70100%
0 to 1.11K
14-Feb-19 10:00 PM
View: 
Tang Kevin C
Director
AP Pharma Inc. (HRTX) 10-Dec-18Gift 37,149----(< 1%)
5.81M to 5.77M
14-Feb-19 10:00 PM
View: 
Tang Kevin C
Director
AP Pharma Inc. (HRTX) 07-Dec-18Gift 39,970----(< 1%)
5.85M to 5.81M
02-Nov-18 9:17 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 02-Nov-18Market Sale (Planned) 494$30.62$15,124.90(100%)
0.49K to 0
10%
02-Nov-18 9:17 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 31-Oct-18Acquisition (other) 494$23.60$11,656.40100%
0 to 0.49K
02-Oct-18 9:12 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 01-Oct-18Market Option Sale (Planned) 6,000$32.07$192,433.00(100%)
6.0K to 0
14%
02-Oct-18 9:12 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 01-Oct-18Option Exercise 6,000$13.00$78,000.00100%
0 to 6.0K
14-Sep-18 11:41 AM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 14-Sep-18Option Exercise 19,675$7.20$141,660.0028%
69.6K to 89.28K
12-Sep-18 12:28 PM
View: 
Tang Kevin C
Director
10% Owner
AP Pharma Inc. (HRTX) 12-Sep-18Market Sale 2,695,000$35.75$96,346,200.00(32%)
8.55M to 5.85M
23%
03-Jul-18 9:01 PM
View: 
Rosen Robert
President
Director
AP Pharma Inc. (HRTX) 02-Jul-18Option Exercise 95,531$7.20$687,823.003619%
2.64K to 98.17K
03-Jul-18 9:03 PM
View: 
Hoffman Robert
CFO & SVP, Finance
AP Pharma Inc. (HRTX) 02-Jul-18Market Option Sale (Planned) 30,000$38.17$1,145,230.00(96%)
31.28K to 1.28K
28%
03-Jul-18 9:05 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 02-Jul-18Option Exercise 6,000$13.00$78,000.00100%
0 to 6.0K
03-Jul-18 9:05 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 02-Jul-18Market Option Sale (Planned) 6,000$37.53$225,179.00(100%)
6.0K to 0
26%
03-Jul-18 9:01 PM
View: 
Rosen Robert
President
Director
AP Pharma Inc. (HRTX) 02-Jul-18Market Option Sale (Planned) 95,531$38.15$3,644,680.00(97%)
98.17K to 2.64K
28%
03-Jul-18 9:03 PM
View: 
Hoffman Robert
CFO & SVP, Finance
AP Pharma Inc. (HRTX) 02-Jul-18Option Exercise 30,000$15.30$459,000.002344%
1.28K to 31.28K
03-Jul-18 9:01 PM
View: 
Rosen Robert
President
Director
AP Pharma Inc. (HRTX) 29-Jun-18Market Option Sale (Planned) 129,469$39.59$5,125,130.00(98%)
132.11K to 2.64K
30%
03-Jul-18 9:01 PM
View: 
Rosen Robert
President
Director
AP Pharma Inc. (HRTX) 29-Jun-18Option Exercise 129,469$7.20$932,177.004904%
2.64K to 132.11K
22-Jun-18 9:35 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 21-Jun-18Option Exercise 50,000$9.05$452,500.0072%
69.6K to 119.6K
22-Jun-18 9:35 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 21-Jun-18Market Option Sale (Planned) 50,000$39.05$1,952,500.00(42%)
119.6K to 69.6K
29%
22-Jun-18 9:35 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 30-Apr-18Acquisition (other) 1,607$13.22$21,240.502%
67.99K to 69.6K
03-Jul-18 9:03 PM
View: 
Hoffman Robert
CFO & SVP, Finance
AP Pharma Inc. (HRTX) 30-Apr-18Acquisition (other) 744$13.22$9,833.82139%
0.54K to 1.28K
02-Apr-18 4:01 PM
View: 
Tang Kevin C
Director
10% Owner
AP Pharma Inc. (HRTX) 29-Mar-18Market Purchase 192,308$26.00$5,000,010.002%
8.35M to 8.55M
6%
19-Mar-18 7:22 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 19-Mar-18Option Exercise 100,000$7.20$720,000.00147%
67.99K to 167.99K
19-Mar-18 7:22 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 19-Mar-18Market Option Sale (Planned) 100,000$29.75$2,975,000.00(60%)
167.99K to 67.99K
7%
19-Mar-18 7:24 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 19-Mar-18Option Exercise 18,000$13.00$234,000.00100%
0 to 18.0K
19-Mar-18 7:24 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 19-Mar-18Market Option Sale (Planned) 18,000$30.00$540,000.00(100%)
18.0K to 0
8%
16-Mar-18 9:00 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 14-Mar-18Option Exercise 100,000$7.20$720,000.00147%
67.99K to 167.99K
16-Mar-18 9:00 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 14-Mar-18Market Option Sale (Planned) 100,000$24.75$2,475,000.00(60%)
167.99K to 67.99K
(12%)
12-Jan-18 4:21 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 10-Jan-18Option Exercise 7,584$13.00$98,592.00100%
0 to 7.58K
12-Jan-18 4:21 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 10-Jan-18Market Option Sale (Planned) 7,584$20.00$151,680.00(100%)
7.58K to 0
(38%)
20-Dec-17 4:13 PM
View: 
Hoffman Robert
CFO & SVP, Finance
AP Pharma Inc. (HRTX) 31-Oct-17Acquisition (other) 536$13.05$6,993.46100%
0 to 0.54K
20-Dec-17 4:15 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 28-Apr-17Acquisition (other) 1,684$12.62$21,256.303%
66.31K to 67.99K
24-Apr-17 8:58 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 24-Apr-17Market Option Sale (Planned) 21,542$15.33$330,263.00(100%)
21.54K to 0
(80%)
24-Apr-17 8:58 PM
View: 
Manhard Kimberly
Executive VP, Drug Development
AP Pharma Inc. (HRTX) 24-Apr-17Option Exercise 21,542$8.99$193,643.00100%
0 to 21.54K
23-Jan-17 4:29 PM
View: 
Poyhonen John
Director
AP Pharma Inc. (HRTX) 19-Jan-17Private Purchase 10,000$12.20$122,000.00100%
0 to 10.0K
23-Jan-17 4:03 PM
View: 
Tang Kevin C
Director
10% Owner
AP Pharma Inc. (HRTX) 19-Jan-17Private Purchase 2,459,020$12.20$30,000,000.0042%
5.9M to 8.35M
23-Dec-16 4:03 PM
View: 
Drazba Brian G.
VP, Finance & CFO
AP Pharma Inc. (HRTX) 31-Oct-16Acquisition (other) 538$12.62$6,790.9117%
3.26K to 3.8K
12-Aug-16 5:14 PM
View: 
Rosen Robert
President & CCO
Director
AP Pharma Inc. (HRTX) 10-Aug-16Market Option Sale (Planned) 100,000$23.30$2,329,890.00(97%)
102.64K to 2.64K
(18%)
12-Aug-16 5:14 PM
View: 
Rosen Robert
President & CCO
Director
AP Pharma Inc. (HRTX) 10-Aug-16Option Exercise 100,000$7.20$720,000.003788%
2.64K to 102.64K
20-Jul-16 8:50 AM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 19-Jul-16Option Exercise 4,630$7.20$33,336.008%
61.68K to 66.31K
20-Jun-16 8:01 PM
View: 
Tang Kevin C
Director
10% Owner
AP Pharma Inc. (HRTX) 16-Jun-16Option Exercise 1,250,000$3.60$4,500,000.0026%
4.89M to 6.14M
20-Jun-16 8:01 PM
View: 
Tang Kevin C
Director
10% Owner
AP Pharma Inc. (HRTX) 16-Jun-16Payment of Exercise 243,639$18.47$4,500,010.00(4%)
6.14M to 5.9M
(49%)
20-Jul-16 8:50 AM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 29-Apr-16Acquisition (other) 837$18.22$15,253.501%
60.84K to 61.68K
23-Dec-16 4:03 PM
View: 
Drazba Brian G.
VP, Finance & CFO
AP Pharma Inc. (HRTX) 29-Apr-16Acquisition (other) 577$18.22$10,515.2022%
2.68K to 3.26K
21-Apr-16 9:27 PM
View: 
Rosen Robert
President
Director
AP Pharma Inc. (HRTX) 21-Apr-16Option Exercise 19,662$7.20$141,566.00745%
2.64K to 22.3K
21-Apr-16 9:27 PM
View: 
Rosen Robert
President
Director
AP Pharma Inc. (HRTX) 21-Apr-16Market Option Sale (Planned) 19,662$22.15$435,433.00(88%)
22.3K to 2.64K
(25%)
21-Apr-16 9:27 PM
View: 
Rosen Robert
President
Director
AP Pharma Inc. (HRTX) 20-Apr-16Option Exercise 4,010$7.20$28,872.00152%
2.64K to 6.65K